Uh-Oh Labs

Executive Summary

Uh-Oh Labs is a San Francisco-based diagnostics company developing an ultra-portable molecular testing platform that delivers PCR-quality results in under 30 minutes. Their proprietary Loop-de-Loop RT-LAMP technology offers a rapid, cost-effective alternative to traditional PCR, enabling infectious disease testing in non-laboratory settings. The company received FDA Emergency Use Authorization for its COVID-19 test and is now expanding its test menu to address other respiratory pathogens and sexually transmitted infections. The global point-of-care diagnostics market is growing rapidly, driven by demand for accessible, lab-accurate testing. Uh-Oh Labs has the potential to disrupt traditional centralized testing by providing a truly portable device suitable for clinics, pharmacies, and remote settings. With its first product on the market and a pipeline of new assays, the company is positioned for growth, though it faces competition from established players and emerging technologies. Key milestones include expanding regulatory approvals and building commercial partnerships.

Upcoming Catalysts (preview)

• Q4 2026FDA clearance for a multiplex respiratory panel70% success
• H2 2026First commercial partnership with a national pharmacy chain60% success
• Q3 2026Series A funding announcement80% success